Welcome to the 3-Part Webinar Series centered around the entire genetics and genomics landscape in Breast Cancer, covering patients at high risk, those who are newly diagnosed, undergoing treatment, or in survivorship. This series will equip you with the expertise to seamlessly integrate genetic and genomic testing into your clinical practice.
In Part One, we will delve into the Foundations and Applications of Germline Testing. Join us as we engage with experts in the field, including Jennifer Lazzara, DNP, ARNP, CGRA, who leads a Breast Cancer Genetics Clinic at Cancer Care Northwest, and Laura Brzeskiewicz, CGC, and Medical Science Liaison Manager at Myriad Genetics.
In Part 2 of our 3-Part series exploring the comprehensive genetics and genomics landscape in breast cancer, we’ll dive into Risk Assessment and High-Risk Management. Come along as we explore strategies and tests to assess breast cancer risk and tools for implementing a high-risk breast program in your practice. Let’s identify patients together who are at high risk for breast cancer so we can #BeatBreastCancer.
In Part 3 of our series diving into the expansive genetics and genomics landscape of breast cancer, we will explore the utilization of genetic testing insights in surgical and treatment decision-making. Join us as we interact with experts to examine the implementation of testing strategies that assist in managing your patients’ new breast cancer diagnoses.
Register for Wednesday, May 22nd at 12:00 PM ET
Objectives
Register for Tuesday, Feb 27th at 12:00 PM ESTRegister for Thursday, Feb 29th at 3:00 PM EST